Found: 7
Select item for more details and to access through your institution.
Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 5, p. 411, doi. 10.1002/dmrr.499
- By:
- Publication type:
- Article
Consistency of continual reassessment method under model misspecification.
- Published in:
- Biometrika, 1996, v. 83, n. 2, p. 395, doi. 10.1093/biomet/83.2.395
- By:
- Publication type:
- Article
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.
- Published in:
- 2010
- By:
- Publication type:
- journal article
DURATION-1. Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks.
- Published in:
- Diabetes Care, 2010, v. 33, n. 6, p. 1255, doi. 10.2337/dc09-1914
- By:
- Publication type:
- Article
Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial.
- Published in:
- Obesity (19307381), 2010, v. 18, n. 9, p. 1739, doi. 10.1038/oby.2009.478
- By:
- Publication type:
- Article